{
  "documentMetadata": {
    "title": "Endocarditis, Gram-negative bacilli",
    "lastUpdated": "2025-01-06",
    "sourceFile": "Endocarditis, Gram-negative bacilli.pdf"
  },
  "content": [
    {
      "type": "header",
      "level": 1,
      "text": "Clinical Setting"
    },
    {
      "type": "list",
      "items": [
        "Specific therapy for endocarditis with blood cultures positive for aerobic gram-negative bacilli.",
        "Signs and symptoms of endocarditis. Patient often has a prosthetic valve."
      ]
    },
    {
      "type": "header",
      "level": 1,
      "text": "Etiologies"
    },
    {
      "type": "list",
      "items": [
        "Enterobacteriaceae",
        "P. aeruginosa"
      ]
    },
    {
      "type": "header",
      "level": 1,
      "text": "Primary Regimens"
    },
    {
      "type": "drugRegimen",
      "regimenData": {
        "intent": "treatment",
        "components": [
          {
            "drug": "Cefepime",
            "dose": "2 gm",
            "route": "IV",
            "frequency": "q8h",
            "connector": "or"
          },
          {
            "drug": "Meropenem",
            "dose": "1 gm",
            "route": "IV",
            "frequency": "q8h",
            "connector": "+"
          },
          {
            "drug": "Tobramycin",
            "dose": "1.5-2 mg/kg",
            "route": "IV",
            "frequency": "q8h"
          }
        ],
        "notes": "Could substitute a fluoroquinolone for the aminoglycoside, see Comment"
      }
    },
    {
      "type": "header",
      "level": 1,
      "text": "Alternative Regimens"
    },
    {
      "type": "drugRegimen",
      "regimenData": {
        "intent": "treatment",
        "components": [
          {
            "drug": "Piperacillin-tazobactam",
            "dose": "4.5 gm",
            "route": "IV",
            "frequency": "q8h",
            "notes": "(over 4 hr)",
            "connector": "+"
          },
          {
            "drug": "Tobramycin",
            "dose": "1.5-2 mg/kg",
            "route": "IV",
            "frequency": "q8h"
          }
        ]
      }
    },
    {
      "type": "header",
      "level": 1,
      "text": "Antimicrobial Stewardship"
    },
    {
      "type": "list",
      "items": [
        "Choice of agents based on in vitro susceptibilities: select definitive regimen to obtain optimal activity.",
        "Infectious Diseases consultation recommended; antibiotic choice dictated by susceptibility data.",
        "Optimal regimens and duration of therapy not well characterized; 6 weeks of therapy is reasonable."
      ]
    },
    {
      "type": "header",
      "level": 1,
      "text": "Comments"
    },
    {
      "type": "list",
      "items": [
        "Fluoroquinolone an option instead of aminoglycoside, but few data; Ann Intern Med. 2007;147:829-835.",
        "A rare, often fatal disease with much uncertainty as to its management.",
        "Medical therapy alone has a high failure rate, so early valve replacement should be considered.",
        "References: Circulation. 2015;132:1435-1486; Infect Dis (Lond). 2023; 55:599."
      ]
    }
  ]
}